Goodyear Tire & Rubber Co vs ImmunityBio Inc. Common Stock — how do they compare? Goodyear Tire & Rubber Co trades at $4.75 (market cap $1.37B), while ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 7.7× Goodyear Tire & Rubber Co's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| GT | IBRX | |
|---|---|---|
Market Cap | $1.37B | $10.51B |
Volume | 9,470,773 | 10,445,785 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $11.55 |
52-Week Low | $4.66 | $1.98 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | $8.72B | $10.97B |
Signals from Pluang's Aura AI — not financial advice
The Goodyear Tire & Rubber Company (GT) trades at $4.69, near its 52-week low, with a bearish technical signal and mixed earnings history. Despite beating EPS estimates in two recent quarters, the company reported a net loss of $1.72 billion in 2025, with negative profit margins and ROE. Cash flow improved slightly in 2025, but high debt levels and declining revenue pose challenges. Recent news highlights restructuring efforts and a 'shrink-to-grow' strategy targeting premium tire segments.
GT presents a high-risk opportunity with a deep value proposition—low P/E and P/B ratios suggest undervaluation, but persistent losses and bearish analyst sentiment indicate significant headwinds. The stock's upside hinges on successful execution of its turnaround plan and margin improvement, while downside risks include ongoing volume pressure and macroeconomic pressures on the auto industry.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →